Diego Correa, M.D., Ph.D. received an M.D. from Pontificia Universidad Javeriana (Bogotá – Colombia); an M.Sc. in Mechanical Engineering from Universidad de Los Andes (Bogotá – Colombia) obtaining the Engineering School Fellowship for academic and research excellence; and a Ph.D. in Cellular and Molecular Physiology from Yale University/Harvard University where he received a full scholarship and was a recipient of the George Robert Pfeiffer Fellowship from the Gustavus and Louise Pfeiffer Research Foundation for excellence. In 2009, he joined the laboratory of Professor Arnold Caplan at the Skeletal Research Center – Case Western Reserve University (Cleveland, OH), where he led the projects related with the biology of adult mesenchymal stem cells (MSCs) and their use in the areas of articular cartilage tissue engineering, and the description of their role as gatekeepers controlling the process of distant cancer metastasis.
Dr. Correa is an expert in mesenchymal stem cells (MSCs) biology and their potential clinical applications in regenerative medicine. His laboratory focuses on various topics including: the identification of functional distinct phenotypic subpopulations of MSCs from bone marrow and adipose tissue, and how these “signatures” impact their performance as cell progenitors, immunomodulators and trophic effectors; how they communicate to each other (e.g., through secreted exosomes) during tissue injury and repair; and the derivation of potential therapeutic applications, using both in vitro and in vivo models, during islet cell transplantation in type 1 diabetes and in joint-related inflammatory and degenerative diseases.
Dr. Correa holds various patent submissions; is author and co-author of a significant number of scientific publications in recognized journals; serves on the editorial board and as a peer reviewer of various recognized scientific journals; serves as a formal reviewer for scientific institutions both nationally (e.g.: California Institute of Regenerative Medicine – CIRM) and internationally (National Medical Research Council of Singapore), and is a frequent invited speaker and lecturer in national and international scientific and medical meetings. Dr. Correa also participates in diverse entrepreneurial activities, such as the creation and evaluation of private start-up companies in the areas of regenerative medicine and adult stem cell-based therapy. He also participates in various Scientific Advisory Boards in companies within the regenerative medicine field in USA and abroad.